Novel soluble myeloid cell leukemia sequence 1 (Mcl-1) inhibitor (E,E)-2-(benzylaminocarbonyl)-3-styrylacrylonitrile (4g) developed using a fragment-based approach

Eur J Med Chem. 2013 Jan:59:141-9. doi: 10.1016/j.ejmech.2012.10.050. Epub 2012 Nov 7.

Abstract

Based on a known nanomolar Bcl-2 homology domain 3 (BH3) mimetic 3-thiomorpholin-8-oxo-8H-acenaphtho[1,2-b] pyrrole-9-carbonitrile (S1, MW: 331), we applied a fragment-based approach to obtain BH3 mimetics with improved affinity and improved solubility in a water-ethanol (9:1) cosolvent. After the deconstruction of 1 (S1), we obtained fragment cyanoacetamide (4), which was determined to be a ligand efficiency (LE) hot part. After a rational optimization through fragment evolution beginning with fragment 4, a smaller Mcl-1 inhibitor (E,E)-2-(benzylaminocarbonyl)-3-styrylacrylonitrile (4g, MW: 288) with a 6-fold increase in affinity compared to 1 was obtained, as predicted by our optimization curve and identified by Mcl-1 protein nuclear magnetic resonance (NMR).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acrylonitrile / analogs & derivatives*
  • Acrylonitrile / chemical synthesis
  • Acrylonitrile / chemistry
  • Acrylonitrile / pharmacology
  • Benzylamines / chemical synthesis
  • Benzylamines / chemistry*
  • Benzylamines / pharmacology
  • Binding Sites
  • Biomimetics
  • Blotting, Western
  • Cell Line, Tumor
  • Humans
  • Inhibitory Concentration 50
  • Magnetic Resonance Spectroscopy
  • Molecular Structure
  • Myeloid Cell Leukemia Sequence 1 Protein
  • Protein Binding / drug effects
  • Proto-Oncogene Proteins c-bcl-2 / antagonists & inhibitors*
  • Solubility / drug effects
  • Structure-Activity Relationship
  • Thermodynamics

Substances

  • (E,E)-2-(benzylaminocarbonyl)-3-styrylacrylonitrile
  • Benzylamines
  • MCL1 protein, human
  • Myeloid Cell Leukemia Sequence 1 Protein
  • Proto-Oncogene Proteins c-bcl-2
  • Acrylonitrile